![Kurt Gustafson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kurt Gustafson
Director of Finance/CFO at
OMNIAB, INC.
Net worth: 783 188 $ as of 2026-05-30
Profile
Kurt A. Gustafson is currently Independent Director at Xencor, Inc. since 2014.
He is Chief Financial Officer & Executive VP-Finance at OmniAb Operations, Inc. and OmniAb, Inc., both since 2022.
Formerly, Mr. Gustafson was Independent Non-Executive Director at Niagen Bioscience, Inc. from 2016 to 2022.
He was Chief Financial Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2013 to 2022.
He served as Chief Financial Officer & Vice President at Halozyme Therapeutics, Inc. from 2012 to 2013.
He was Chief Financial Officer & VP-Manufacturing Finance at Amgen, Inc. in 2009.
He held the position of Chief Financial Officer & Vice President-Finance at Amgen Europe BV from 2004 to 2006.
He worked at Amgen International AG as Chief Financial Officer, Treasurer & VP.
He was Staff Auditor at Horwath Velez & Co. PSC.
Education includes an MBA from the University of California, Los Angeles and an undergraduate degree from North Park University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OMNIAB, INC. 0.18% | 2026-04-22 | 261,483 ( 0.18% ) | 706 004 $ | 2026-05-30 |
XENCOR, INC. 0.01% | 2026-02-27 | 6,497 ( 0.01% ) | 77 184 $ | 2026-05-30 |
Kurt Gustafson active positions
| Companies | Position | Start |
|---|---|---|
| XENCOR, INC. | Director/Board Member | 2014-07-24 |
| OMNIAB, INC. | Director of Finance/CFO | 2022-02-28 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Director of Finance/CFO | 2022-02-28 |
Former positions of Kurt Gustafson
| Companies | Position | End |
|---|---|---|
| NIAGEN BIOSCIENCE, INC. | Director/Board Member | 2022-06-15 |
| SPECTRUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2022-03-17 |
| HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 2013-05-19 |
| AMGEN INC. | Director of Finance/CFO | 2008-12-31 |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Director of Finance/CFO | 2005-12-31 |
Training of Kurt Gustafson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Park University
 North Park University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horwath Velez & Co. PSC
 Horwath Velez & Co. PSC Miscellaneous Commercial ServicesCommercial Services Horwath Velez & Co. PSC is a private company based in Washington, DC. | Commercial Services |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
Amgen International AG | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
- Stock Market
- Insiders
- Kurt Gustafson
